{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:25:42Z","timestamp":1794565542071,"version":"4.9.1"},"reference-count":308,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000143","name":"Alzheimer Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000143","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de recherche du Qu\u00e9bec Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.expneurol.2026.115806","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:23:22Z","timestamp":1778282602000},"page":"115806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The emerging role of polo-like kinase 2 in Alzheimer's disease"],"prefix":"10.1016","volume":"403","author":[{"given":"Laura","family":"Mart\u00ednez-Drudis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan","family":"Sheta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Musiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid","family":"Oueslati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2026.115806_bb0005","series-title":"Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD), Biogen, Editor","author":"A Phase 2a","year":"2024"},{"key":"10.1016\/j.expneurol.2026.115806_bb0010","series-title":"Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants With Parkinson's Disease, I. Denali Therapeutics, Editor","author":"A Phase 2b","year":"2022"},{"key":"10.1016\/j.expneurol.2026.115806_bb0015","series-title":"Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122\/DNL151 in Participants With Parkinson's Disease and Pathogenic LRRK2 Variants, I. Denali Therapeutics, Editor","author":"A Phase 3","year":"2022"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0020","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/jnc.15948","article-title":"Plk2 promotes synaptic destabilization through disruption of N-cadherin adhesion complexes during homeostatic adaptation to hyperexcitation","volume":"167","author":"Abdel-Ghani","year":"2023","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115806_bb0025","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1073\/pnas.91.12.5562","article-title":"Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease","volume":"91","author":"Alonso","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2026.115806_bb0030","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fncel.2018.00338","article-title":"Hyperphosphorylation of Tau associates with changes in its function beyond microtubule stability","volume":"12","author":"Alonso","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115806_bb0035","series-title":"World Alzheimer Report 2019 Attitudes to dementia","author":"Alzheimer\u2019s Disease International","year":"2019"},{"issue":"9","key":"10.1016\/j.expneurol.2026.115806_bb0040","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1093\/nar\/gkq011","article-title":"The novel mouse Polo-like kinase 5 responds to DNA damage and localizes in the nucleolus","volume":"38","author":"Andrysik","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"43","key":"10.1016\/j.expneurol.2026.115806_bb0045","doi-asserted-by":"crossref","first-page":"29424","DOI":"10.1074\/jbc.M802475200","article-title":"Regulation of postsynaptic RapGAP SPAR by Polo-like kinase 2 and the SCFbeta-TRCP ubiquitin ligase in hippocampal neurons","volume":"283","author":"Ang","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb0050","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1471-4159.1996.67020699.x","article-title":"In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3beta","volume":"67","author":"Aplin","year":"1996","journal-title":"J. Neurochem."},{"issue":"18","key":"10.1016\/j.expneurol.2026.115806_bb0055","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1097\/00001756-199611250-00050","article-title":"Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer\u2019s disease","volume":"7","author":"Arendt","year":"1996","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.mcna.2018.10.009","article-title":"The Alzheimer's disease clinical spectrum: diagnosis and management","volume":"103","author":"Atri","year":"2019","journal-title":"Med. Clin. North Am."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115806_bb0065","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/cmdc.201300166","article-title":"Selective and brain-permeable polo-like kinase-2 (Plk-2) inhibitors that reduce alpha-synuclein phosphorylation in rat brain","volume":"8","author":"Aubele","year":"2013","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.00024.2003","article-title":"Role of tau protein in both physiological and pathological conditions","volume":"84","author":"Avila","year":"2004","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0075","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10637-015-0223-9","article-title":"Phase I trial of volasertib, a Polo-like kinase inhibitor, plus platinum agents in solid tumors: safety, pharmacokinetics and activity","volume":"33","author":"Awada","year":"2015","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.expneurol.2026.115806_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2015.06.008","article-title":"Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease","volume":"52","author":"Barage","year":"2015","journal-title":"Neuropeptides"},{"issue":"11","key":"10.1016\/j.expneurol.2026.115806_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015503","article-title":"Tyr(682) in the intracellular domain of APP regulates amyloidogenic APP processing in vivo","volume":"5","author":"Barbagallo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2026.115806_bb0090","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnagi.2019.00204","article-title":"Role of tau as a microtubule-associated protein: structural and functional aspects","volume":"11","author":"Barbier","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb0095","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrm1401","article-title":"Polo-like kinases and the orchestration of cell division","volume":"5","author":"Barr","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb0100","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nn.2801","article-title":"Neuronal activity regulates the regional vulnerability to amyloid-beta deposition","volume":"14","author":"Bero","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115806_bb0105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.72.121801.161800","article-title":"Signals for sorting of transmembrane proteins to endosomes and lysosomes","volume":"72","author":"Bonifacino","year":"2003","journal-title":"Annu. Rev. Biochem."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115806_bb0110","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.bmcl.2013.02.065","article-title":"Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors","volume":"23","author":"Bowers","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.expneurol.2026.115806_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.702788","article-title":"Human tau isoforms and proteolysis for production of toxic tau fragments in neurodegeneration","volume":"15","author":"Boyarko","year":"2021","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb0120","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115806_bb0125","article-title":"Influence of the onset of menopause on the risk of developing Alzheimer's disease","volume":"16","author":"Briceno Silva","year":"2024","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.expneurol.2026.115806_bb0130","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1021\/acscentsci.1c00585","article-title":"A structural ensemble of a tau-microtubule complex reveals regulatory tau phosphorylation and acetylation mechanisms","volume":"7","author":"Brotzakis","year":"2021","journal-title":"ACS Cent. Sci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Buee","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/WAD.0000000000000002","article-title":"Reelin signaling pathway genotypes and Alzheimer disease in a Spanish population","volume":"29","author":"Bufill","year":"2015","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"32","key":"10.1016\/j.expneurol.2026.115806_bb0145","doi-asserted-by":"crossref","first-page":"11707","DOI":"10.1073\/pnas.0306880101","article-title":"The mouse kinome: discovery and comparative genomics of all mouse protein kinases","volume":"101","author":"Caenepeel","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0150","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.mcn.2003.10.008","article-title":"Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus","volume":"25","author":"Cardona-Gomez","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115806_bb0155","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1128\/MCB.02393-05","article-title":"Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration","volume":"26","author":"Chang","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb0160","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1016\/S0021-9258(19)39742-X","article-title":"NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor","volume":"265","author":"Chen","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115806_bb0165","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"488","key":"10.1016\/j.expneurol.2026.115806_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aam6790","article-title":"Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's disease","volume":"10","author":"Chen","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.expneurol.2026.115806_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.903016","article-title":"Present and future perspective on PLK1 inhibition in cancer treatment","volume":"12","author":"Chiappa","year":"2022","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115806_bb0180","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/jnen\/59.11.966","article-title":"Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: a fluorescence resonance energy transfer study","volume":"59","author":"Chin","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1074\/jbc.M206236200","article-title":"Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding","volume":"278","author":"Cho","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.expneurol.2026.115806_bb0190","doi-asserted-by":"crossref","first-page":"14066","DOI":"10.1074\/jbc.M114.558155","article-title":"Plk1 protein phosphorylates phosphatase and tensin homolog (PTEN) and regulates its mitotic activity during the cell cycle","volume":"289","author":"Choi","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","article-title":"An overview of APP processing enzymes and products","volume":"12","author":"Chow","year":"2010","journal-title":"NeuroMolecular Med."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0200","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2008.02.003","article-title":"Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo","volume":"58","author":"Cirrito","year":"2008","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.expneurol.2026.115806_bb0205","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1073\/pnas.90.11.4882","article-title":"Identification and cloning of a protein kinase-encoding mouse gene, Plk, related to the polo gene of Drosophila","volume":"90","author":"Clay","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115806_bb0210","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1212\/01.WNL.0000140626.48118.0A","article-title":"A focus on the synapse for neuroprotection in Alzheimer disease and other dementias","volume":"63","author":"Coleman","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0215","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.nbd.2008.12.014","article-title":"JNK regulates APP cleavage and degradation in a model of Alzheimer\u2019s disease","volume":"33","author":"Colombo","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/14728222.2016.1091883","article-title":"Casein kinases as potential therapeutic targets","volume":"20","author":"Cozza","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2026.115806_bb0225","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1385\/JMN:23:1-2:123","article-title":"Signal transduction therapeutics: relevance for Alzheimer\u2019s disease","volume":"23","author":"da Cruze Silva","year":"2004","journal-title":"J. Mol. Neurosci."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115806_bb0230","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1074\/jbc.M116.759373","article-title":"Dissecting the Molecular Pathway Involved in PLK2 Kinase-mediated alpha-synuclein-selective autophagic degradation","volume":"292","author":"Dahmene","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb0235","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/sj.onc.1208270","article-title":"Polo-like kinases, an introduction","volume":"24","author":"Dai","year":"2005","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb0240","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0092-8674(01)00374-9","article-title":"Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition","volume":"105","author":"Dajani","year":"2001","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.expneurol.2026.115806_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077053","article-title":"A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1","volume":"8","author":"Danovi","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0250","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neuron.2013.05.035","article-title":"Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway","volume":"79","author":"Das","year":"2013","journal-title":"Neuron"},{"issue":"14","key":"10.1016\/j.expneurol.2026.115806_bb0255","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.4161\/cc.10.14.16494","article-title":"From Plk1 to Plk5: functional evolution of polo-like kinases","volume":"10","author":"de Carcer","year":"2011","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb0260","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/MCB.00607-10","article-title":"Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression","volume":"31","author":"de Carcer","year":"2011","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb0265","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1158\/1078-0432.CCR-09-1380","article-title":"Targeting Polo-like kinase in cancer therapy","volume":"16","author":"Degenhardt","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115806_bb0270","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410270502","article-title":"Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity","volume":"27","author":"DeKosky","year":"1990","journal-title":"Ann. Neurol."},{"issue":"13","key":"10.1016\/j.expneurol.2026.115806_bb0275","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1523\/JNEUROSCI.5980-08.2009","article-title":"A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses","volume":"29","author":"Deshpande","year":"2009","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115806_bb0280","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.4103\/1673-5374.253509","article-title":"Exploring the efficacy of natural products in alleviating Alzheimer's disease","volume":"14","author":"Deshpande","year":"2019","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0285","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115806_bb0290","first-page":"595","article-title":"The role of tau kinases in Alzheimer's disease","volume":"13","author":"Dolan","year":"2010","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"10.1016\/j.expneurol.2026.115806_bb0295","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fnmol.2019.00163","article-title":"Recruitment, retainment, and biomarkers of response; a pilot trial of lithium in humans with mild cognitive impairment","volume":"12","author":"Duthie","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115806_bb0300","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fnmol.2014.00057","article-title":"Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis","volume":"7","author":"Dzamko","year":"2014","journal-title":"Front. Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115806_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252635","article-title":"Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein","volume":"16","author":"Elfarrash","year":"2021","journal-title":"PLoS One"},{"issue":"5610","key":"10.1016\/j.expneurol.2026.115806_bb0310","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1079079","article-title":"Proteomic screen finds pSer\/pThr-binding domain localizing Plk1 to mitotic substrates","volume":"299","author":"Elia","year":"2003","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002607","article-title":"Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer's disease","volume":"22","author":"Eteleeb","year":"2024","journal-title":"PLoS Biol."},{"key":"10.1016\/j.expneurol.2026.115806_bb0320","series-title":"O. University of, Editor","author":"Evaluation of Lithium as a Glycogen-Synthase-Kinase-3 (GSK-3) Inhibitor in Mild Cognitive Impairment","year":"2015"},{"issue":"10","key":"10.1016\/j.expneurol.2026.115806_bb0325","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/nn.2624","article-title":"Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic overexcitation","volume":"13","author":"Evers","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"22","key":"10.1016\/j.expneurol.2026.115806_bb0330","doi-asserted-by":"crossref","first-page":"11960","DOI":"10.1073\/pnas.220413597","article-title":"Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A","volume":"97","author":"Fang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"24","key":"10.1016\/j.expneurol.2026.115806_bb0335","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1038\/sj.emboj.7600887","article-title":"A cell-autonomous requirement for the cell cycle regulatory protein, Rb, in neuronal migration","volume":"24","author":"Ferguson","year":"2005","journal-title":"EMBO J."},{"issue":"4\u20135","key":"10.1016\/j.expneurol.2026.115806_bb0340","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/15216540701283882","article-title":"Soluble protein oligomers as emerging toxins in Alzheimer\u2019s and other amyloid diseases","volume":"59","author":"Ferreira","year":"2007","journal-title":"IUBMB Life"},{"issue":"12","key":"10.1016\/j.expneurol.2026.115806_bb0345","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s007020100016","volume":"108","author":"Ferrer","year":"2001","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb0350","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2005.03.020","article-title":"Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models","volume":"20","author":"Ferrer","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2013.02.012","article-title":"Pharmacological inhibition of polo like kinase 2 (PLK2) does not cause chromosomal damage or result in the formation of micronuclei","volume":"269","author":"Fitzgerald","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115806_bb0360","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1192\/bjp.2019.76","article-title":"Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial","volume":"215","author":"Forlenza","year":"2019","journal-title":"Br. J. Psychiatry"},{"issue":"17","key":"10.1016\/j.expneurol.2026.115806_bb0365","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1523\/JNEUROSCI.4261-13.2014","article-title":"Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers","volume":"34","author":"Frandemiche","year":"2014","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0370","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neuron.2009.03.029","article-title":"Alternative functions of core cell cycle regulators in neuronal migration, neuronal maturation, and synaptic plasticity","volume":"62","author":"Frank","year":"2009","journal-title":"Neuron"},{"issue":"16","key":"10.1016\/j.expneurol.2026.115806_bb0375","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1073\/pnas.85.16.6218","article-title":"Phosphorylation of Alzheimer disease amyloid precursor peptide by protein kinase C and Ca2+\/calmodulin-dependent protein kinase II","volume":"85","author":"Gandy","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"23","key":"10.1016\/j.expneurol.2026.115806_bb0380","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.2174\/092986712802002455","article-title":"Polo-like kinases inhibitors","volume":"19","author":"Garuti","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0385","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1097-4547(19960401)44:1<12::AID-JNR2>3.0.CO;2-L","article-title":"Microtubule assembly competence analysis of freshly-biopsied human tau, dephosphorylated tau, and Alzheimer tau","volume":"44","author":"Garver","year":"1996","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb0390","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0002-9440(10)65219-4","article-title":"A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer\u2019s disease","volume":"155","author":"Ghoshal","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"20","key":"10.1016\/j.expneurol.2026.115806_bb0395","doi-asserted-by":"crossref","first-page":"11317","DOI":"10.1073\/pnas.96.20.11317","article-title":"Expression of the CDH1-associated form of the anaphase-promoting complex in postmitotic neurons","volume":"96","author":"Gieffers","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.expneurol.2026.115806_bb0400","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1101\/lm.028449.112","article-title":"The roles of protein kinases in learning and memory","volume":"20","author":"Giese","year":"2013","journal-title":"Learn. Mem."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0405","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/leu.2014.222","article-title":"Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy","volume":"29","author":"Gjertsen","year":"2015","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0410","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Pt 6","key":"10.1016\/j.expneurol.2026.115806_bb0415","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1242\/jcs.107.6.1509","article-title":"Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5","volume":"107","author":"Golsteyn","year":"1994","journal-title":"J. Cell Sci."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0420","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/iub.308","article-title":"Role of the SNK-SPAR pathway in the development of Alzheimer\u2019s disease","volume":"62","author":"Gong","year":"2010","journal-title":"IUBMB Life"},{"issue":"24","key":"10.1016\/j.expneurol.2026.115806_bb0425","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1016\/S0021-9258(18)41866-2","article-title":"Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes","volume":"267","author":"Goode","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0430","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1503\/jpn.140062","article-title":"Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline","volume":"40","author":"Gourmaud","year":"2015","journal-title":"J. Psychiatry Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0435","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pneurobio.2007.02.001","article-title":"Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts","volume":"82","author":"Gralle","year":"2007","journal-title":"Prog. Neurobiol."},{"issue":"13","key":"10.1016\/j.expneurol.2026.115806_bb0440","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.expneurol.2026.115806_bb0445","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1016\/j.celrep.2018.08.001","article-title":"Transcriptional and translational differences of microglia from male and female brains","volume":"24","author":"Guneykaya","year":"2018","journal-title":"Cell Rep."},{"issue":"21","key":"10.1016\/j.expneurol.2026.115806_bb0450","doi-asserted-by":"crossref","first-page":"9424","DOI":"10.18632\/aging.102394","article-title":"Neuroprotective effects of protocatechuic aldehyde through PLK2\/p-GSK3beta\/Nrf2 signaling pathway in both in vivo and in vitro models of Parkinson's disease","volume":"11","author":"Guo","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb0455","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2174\/1570159X18666200123165652","article-title":"The critical period for neuroprotection by estrogen replacement therapy and the potential underlying mechanisms","volume":"18","author":"Guo","year":"2020","journal-title":"Curr. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb0460","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0014-5793(92)80767-B","article-title":"The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs","volume":"307","author":"Gustke","year":"1992","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb0465","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb0470","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1083\/jcb.128.4.537","article-title":"Polarized sorting of beta-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals","volume":"128","author":"Haass","year":"1995","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115806_bb0475","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1002\/anie.201913001","article-title":"Site-specific hyperphosphorylation inhibits, rather than promotes, tau fibrillization, seeding capacity, and its microtubule binding","volume":"59","author":"Haj-Yahya","year":"2020","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0480","first-page":"249","article-title":"Cloning and characterization of human and murine homologues of the Drosophila polo serine-threonine kinase","volume":"5","author":"Hamanaka","year":"1994","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.expneurol.2026.115806_bb0485","author":"Hanger"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0490","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","article-title":"Tau phosphorylation: the therapeutic challenge for neurodegenerative disease","volume":"15","author":"Hanger","year":"2009","journal-title":"Trends Mol. Med."},{"issue":"5054","key":"10.1016\/j.expneurol.2026.115806_bb0495","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"5580","key":"10.1016\/j.expneurol.2026.115806_bb0500","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb0505","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0197-4580(00)00218-9","article-title":"Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes","volume":"21","author":"Harris","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"24","key":"10.1016\/j.expneurol.2026.115806_bb0510","doi-asserted-by":"crossref","first-page":"17047","DOI":"10.1016\/S0021-9258(18)41890-X","article-title":"Protein sequence and mass spectrometric analyses of tau in the Alzheimer\u2019s disease brain","volume":"267","author":"Hasegawa","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb0515","first-page":"8060","article-title":"Estradiol suppresses phosphorylation of ERalpha serine 167 through upregulation of PP2A in breast cancer cells","volume":"14","author":"Hayashi","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.expneurol.2026.115806_bb0520","doi-asserted-by":"crossref","first-page":"30319","DOI":"10.1038\/srep30319","article-title":"Altered protein phosphorylation as a resource for potential AD biomarkers","volume":"6","author":"Henriques","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115806_bb0525","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1046\/j.1471-4159.1999.0722053.x","article-title":"p38 kinase is activated in the Alzheimer\u2019s disease brain","volume":"72","author":"Hensley","year":"1999","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115806_bb0530","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/35104061","article-title":"Dendritic spines: structure, dynamics and regulation","volume":"2","author":"Hering","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"49","key":"10.1016\/j.expneurol.2026.115806_bb0535","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1523\/JNEUROSCI.2508-13.2013","article-title":"Pharmacologic inhibition of ROCK2 suppresses amyloid-beta production in an Alzheimer\u2019s disease mouse model","volume":"33","author":"Herskowitz","year":"2013","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb0540","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer\u2019s disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115806_bb0545","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13001","article-title":"Rho-associated coiled-coil kinase 1 activation mediates amyloid precursor protein site-specific Ser655 phosphorylation and triggers amyloid pathology","volume":"18","author":"Hu","year":"2019","journal-title":"Aging Cell"},{"issue":"11","key":"10.1016\/j.expneurol.2026.115806_bb0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111975","article-title":"17beta-estradiol modulates gene expression in the female mouse cerebral cortex","volume":"9","author":"Humphreys","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0555","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/j.1460-2075.1994.tb06291.x","article-title":"Selective ectodomain phosphorylation and regulated cleavage of beta-amyloid precursor protein","volume":"13","author":"Hung","year":"1994","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0560","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.1471-4159.2000.0751085.x","article-title":"Neuron-specific phosphorylation of Alzheimer\u2019s beta-amyloid precursor protein by cyclin-dependent kinase 5","volume":"75","author":"Iijima","year":"2000","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115806_bb0565","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1074\/jbc.C800206200","article-title":"Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system","volume":"284","author":"Inglis","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2026.115806_bb0570","series-title":"World Alzheimer Report 2024: Global changes in attitudes to dementia","author":"International, A.s.D","year":"2024"},{"issue":"8504","key":"10.1016\/j.expneurol.2026.115806_bb0575","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0140-6736(86)92134-3","article-title":"Defective brain microtubule assembly in Alzheimer\u2019s disease","volume":"2","author":"Iqbal","year":"1986","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0580","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0014-5793(94)00650-4","article-title":"Alzheimer paired helical filaments. Restoration of the biological activity by dephosphorylation","volume":"349","author":"Iqbal","year":"1994","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115806_bb0585","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0590","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: the story so far","volume":"12","author":"Iqbal","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0595","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/bbrc.2000.2926","article-title":"Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta","volume":"273","author":"Isagawa","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb0600","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/bbrc.1999.0637","article-title":"Phosphorylation of the cytoplasmic domain of Alzheimer\u2019s beta-amyloid precursor protein at Ser655 by a novel protein kinase","volume":"258","author":"Isohara","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0605","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","article-title":"Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk","volume":"51","author":"Jansen","year":"2019","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115806_bb0610","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1210\/en.2012-1464","article-title":"17beta-estradiol and progesterone regulate expression of beta-amyloid clearance factors in primary neuron cultures and female rat brain","volume":"153","author":"Jayaraman","year":"2012","journal-title":"Endocrinology"},{"issue":"648","key":"10.1016\/j.expneurol.2026.115806_bb0615","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj2658","article-title":"Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease","volume":"14","author":"Jennings","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"Pt 24","key":"10.1016\/j.expneurol.2026.115806_bb0620","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1242\/jcs.01558","article-title":"Tau phosphorylation in neuronal cell function and dysfunction","volume":"117","author":"Johnson","year":"2004","journal-title":"J. Cell Sci."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2026.115806_bb0625","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12031-009-9237-0","article-title":"Nicotinic receptors, amyloid-beta, and synaptic failure in Alzheimer\u2019s disease","volume":"40","author":"Jurgensen","year":"2010","journal-title":"J. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb0630","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"issue":"20","key":"10.1016\/j.expneurol.2026.115806_bb0635","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1093\/emboj\/18.20.5528","article-title":"The polo-like protein kinases Fnk and Snk associate with a Ca(2+)- and integrin-binding protein and are regulated dynamically with synaptic plasticity","volume":"18","author":"Kauselmann","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2026.115806_bb0640","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3389\/fphar.2018.00738","article-title":"Casein kinase 1delta\/epsilon Inhibitor, PF670462 attenuates the fibrogenic effects of transforming growth factor-beta in pulmonary fibrosis","volume":"9","author":"Keenan","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"6394","key":"10.1016\/j.expneurol.2026.115806_bb0645","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1126\/science.aat1780","article-title":"Near-atomic model of microtubule-tau interactions","volume":"360","author":"Kellogg","year":"2018","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb0650","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.cell.2008.11.050","article-title":"A centrosomal Cdc20-APC pathway controls dendrite morphogenesis in postmitotic neurons","volume":"136","author":"Kim","year":"2009","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.expneurol.2026.115806_bb0655","first-page":"2498","article-title":"Inhibition of death-associated protein kinase 1 attenuates the phosphorylation and amyloidogenic processing of amyloid precursor protein","volume":"25","author":"Kim","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"16","key":"10.1016\/j.expneurol.2026.115806_bb0660","doi-asserted-by":"crossref","first-page":"14257","DOI":"10.1074\/jbc.M111.219311","article-title":"Combinatorial Tau pseudophosphorylation: markedly different regulatory effects on microtubule assembly and dynamic instability than the sum of the individual parts","volume":"286","author":"Kiris","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/mcp.O116.064188","article-title":"Extracellular protein phosphorylation, the neglected side of the modification","volume":"16","author":"Klement","year":"2017","journal-title":"Mol. Cell. Proteomics"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb0670","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1006\/bbrc.1993.2490","article-title":"Serine phosphorylation of the secreted extracellular domain of APP","volume":"197","author":"Knops","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2026.115806_bb0675","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2017.06.014","article-title":"Polo-like kinase 2 modulates alpha-synuclein protein levels by regulating its mRNA production","volume":"106","author":"Kofoed","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2026.115806_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104720","article-title":"Glycogen synthase kinase 3 beta activity is essential for Polo-like kinase 2- and Leucine-rich repeat kinase 2-mediated regulation of alpha-synuclein","volume":"136","author":"Kofoed","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"26","key":"10.1016\/j.expneurol.2026.115806_bb0685","doi-asserted-by":"crossref","first-page":"17386","DOI":"10.1016\/S0021-9258(17)32449-3","article-title":"Evidence that production and release of amyloid beta-protein involves the endocytic pathway","volume":"269","author":"Koo","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2026.115806_bb0690","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/705745","article-title":"PLK-1 targeted inhibitors and their potential against tumorigenesis","volume":"2015","author":"Kumar","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115806_bb0695","doi-asserted-by":"crossref","first-page":"803","DOI":"10.18632\/aging.100362","article-title":"Phosphorylation of amyloid beta (Abeta) peptides - a trigger for formation of toxic aggregates in Alzheimer\u2019s disease","volume":"3","author":"Kumar","year":"2011","journal-title":"Aging (Albany NY)"},{"issue":"11","key":"10.1016\/j.expneurol.2026.115806_bb0700","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1038\/emboj.2011.138","article-title":"Extracellular phosphorylation of the amyloid beta-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer\u2019s disease","volume":"30","author":"Kumar","year":"2011","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115806_bb0705","doi-asserted-by":"crossref","DOI":"10.3390\/biom15101365","article-title":"Targeting a Tau kinase Cdk5, cyclin-dependent kinase: a blood-based diagnostic marker and therapeutic earmark for Alzheimer's disease","volume":"15","author":"Kumari","year":"2025","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0710","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/alzrt258","article-title":"Truncated and modified amyloid-beta species","volume":"6","author":"Kummer","year":"2014","journal-title":"Alzheimers Res. Ther."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115806_bb0715","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s41588-019-0495-7","article-title":"Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb0720","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1046\/j.1471-4159.1997.69062506.x","article-title":"Casein kinase 1 is tightly associated with paired-helical filaments isolated from Alzheimer\u2019s disease brain","volume":"69","author":"Kuret","year":"1997","journal-title":"J. Neurochem."},{"issue":"45","key":"10.1016\/j.expneurol.2026.115806_bb0725","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1523\/JNEUROSCI.3432-04.2004","article-title":"Synaptic targeting by Alzheimer\u2019s-related amyloid beta oligomers","volume":"24","author":"Lacor","year":"2004","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115806_bb0730","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1074\/jbc.270.8.3565","article-title":"Characterization of sorting signals in the beta-amyloid precursor protein cytoplasmic domain","volume":"270","author":"Lai","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115806_bb0735","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0740","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/mcne.2002.1108","article-title":"Cyclin-dependent kinase-5\/p35 phosphorylates Presenilin 1 to regulate carboxy-terminal fragment stability","volume":"20","author":"Lau","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115806_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118664","article-title":"Glycogen synthase kinase-3 signaling in Alzheimer's disease","volume":"1867","author":"Lauretti","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0750","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.pharmthera.2006.06.003","article-title":"Synaptic plasticity and phosphorylation","volume":"112","author":"Lee","year":"2006","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0755","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1083\/jcb.200301115","article-title":"APP processing is regulated by cytoplasmic phosphorylation","volume":"163","author":"Lee","year":"2003","journal-title":"J. Cell Biol."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115806_bb0760","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.neuron.2011.02.004","article-title":"Requirement for Plk2 in orchestrated ras and rap signaling, homeostatic structural plasticity, and memory","volume":"69","author":"Lee","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2026.115806_bb0765","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neuropharm.2017.02.027","article-title":"Polo-like kinase 2 phosphorylation of amyloid precursor protein regulates activity-dependent amyloidogenic processing","volume":"117","author":"Lee","year":"2017","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115806_bb0770","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219691","article-title":"Inhibition of Polo-like kinase 2 ameliorates pathogenesis in Alzheimer's disease model mice","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115806_bb0775","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0780","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2990.2006.00795.x","article-title":"Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration","volume":"33","author":"Leroy","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0785","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00702-005-0303-7","article-title":"Activation of glycogen synthase kinase-3 induces Alzheimer-like tau hyperphosphorylation in rat hippocampus slices in culture","volume":"113","author":"Li","year":"2006","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.expneurol.2026.115806_bb0790","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.freeradbiomed.2014.05.022","article-title":"Polo-like kinase 2 activates an antioxidant pathway to promote the survival of cells with mitochondrial dysfunction","volume":"73","author":"Li","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115806_bb0795","doi-asserted-by":"crossref","first-page":"9882","DOI":"10.18632\/aging.103253","article-title":"Systematic metabolic analysis of potential target, therapeutic drug, diagnostic method and animal model applicability in three neurodegenerative diseases","volume":"12","author":"Li","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb0800","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1471-4159.2007.04792.x","article-title":"The binding and phosphorylation of Thr231 is critical for Tau\u2019s hyperphosphorylation and functional regulation by glycogen synthase kinase 3beta","volume":"103","author":"Lin","year":"2007","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0805","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.tranon.2015.03.010","article-title":"Targeting polo-like kinases: a promising therapeutic approach for cancer treatment","volume":"8","author":"Liu","year":"2015","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0810","first-page":"228","article-title":"Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments","volume":"146","author":"Liu","year":"1995","journal-title":"Am. J. Pathol."},{"issue":"1-3","key":"10.1016\/j.expneurol.2026.115806_bb0815","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-5793(03)00714-2","article-title":"Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35\/Cdk5 and p25\/Cdk5","volume":"547","author":"Liu","year":"2003","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115806_bb0820","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","article-title":"Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation","volume":"22","author":"Liu","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115806_bb0825","first-page":"46","article-title":"GSK-3beta, a pivotal kinase in Alzheimer disease","volume":"7","author":"Llorens-Martin","year":"2014","journal-title":"Front. Mol. Neurosci."},{"issue":"41","key":"10.1016\/j.expneurol.2026.115806_bb0830","doi-asserted-by":"crossref","first-page":"16293","DOI":"10.1073\/pnas.1315622110","article-title":"Silencing synuclein at the synapse with PLK2","volume":"110","author":"Looyenga","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.expneurol.2026.115806_bb0835","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1007\/s11064-009-0017-6","article-title":"Decrease of Tau hyperphosphorylation by 17beta estradiol requires sphingosine kinase in a glutamate toxicity model","volume":"34","author":"Lopez-Tobon","year":"2009","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0840","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in Alzheimer's disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2026.115806_bb0845","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.yjmcc.2016.11.003","article-title":"Roles and regulation of protein phosphatase 2A (PP2A) in the heart","volume":"101","author":"Lubbers","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115806_bb0850","first-page":"376","article-title":"The serum-inducible protein kinase Snk is a G1 phase polo-like kinase that is inhibited by the calcium- and integrin-binding protein CIB","volume":"1","author":"Ma","year":"2003","journal-title":"Mol. Cancer Res."},{"issue":"19","key":"10.1016\/j.expneurol.2026.115806_bb0855","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1128\/MCB.23.19.6936-6943.2003","article-title":"Role of Plk2 (Snk) in mouse development and cell proliferation","volume":"23","author":"Ma","year":"2003","journal-title":"Mol. Cell. Biol."},{"issue":"1-3","key":"10.1016\/j.expneurol.2026.115806_bb0860","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0169-328X(92)90071-I","article-title":"In situ hybridization of calcium\/calmodulin dependent protein kinase II and tau mRNAs; species differences and relative preservation in Alzheimer's disease","volume":"12","author":"Mah","year":"1992","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115806_bb0865","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1021\/acs.analchem.5b04509","article-title":"FLEXITau: quantifying post-translational modifications of tau protein in vitro and in human disease","volume":"88","author":"Mair","year":"2016","journal-title":"Anal. Chem."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115806_bb0870","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0962-8924(98)01368-3","article-title":"Tau in Alzheimer\u2019s disease","volume":"8","author":"Mandelkow","year":"1998","journal-title":"Trends Cell Biol."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115806_bb0875","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.tins.2006.10.004","article-title":"Protein serine\/threonine phosphatases in neuronal plasticity and disorders of learning and memory","volume":"29","author":"Mansuy","year":"2006","journal-title":"Trends Neurosci."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb0880","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neuint.2010.12.023","article-title":"Post-translational modifications of tau protein: implications for Alzheimer\u2019s disease","volume":"58","author":"Martin","year":"2011","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0885","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","article-title":"Tau protein kinases: involvement in Alzheimer's disease","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2026.115806_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105833","article-title":"Inhibition of PLK2 activity affects APP and tau pathology and improves synaptic content in a sex-dependent manner in a 3xTg mouse model of Alzheimer's disease","volume":"172","author":"Martinez-Drudis","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"20","key":"10.1016\/j.expneurol.2026.115806_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39571","article-title":"Pharmacological inhibition of PLK2 kinase activity mitigates cognitive decline but aggravates APP pathology in a sex-dependent manner in APP\/PS1 mouse model of Alzheimer's disease","volume":"10","author":"Martinez-Drudis","year":"2024","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb0900","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1523\/JNEUROSCI.3920-04.2005","article-title":"Collaboration of PSD-Zip70 with its binding partner, SPAR, in dendritic spine maturity","volume":"25","author":"Maruoka","year":"2005","journal-title":"J. Neurosci."},{"issue":"33","key":"10.1016\/j.expneurol.2026.115806_bb0905","doi-asserted-by":"crossref","first-page":"11756","DOI":"10.1523\/JNEUROSCI.1960-11.2011","article-title":"APP is phosphorylated by TrkA and regulates NGF\/TrkA signaling","volume":"31","author":"Matrone","year":"2011","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb0910","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/acel.12009","article-title":"Tyr682 in the Abeta-precursor protein intracellular domain regulates synaptic connectivity, cholinergic function, and cognitive performance","volume":"11","author":"Matrone","year":"2012","journal-title":"Aging Cell"},{"issue":"47","key":"10.1016\/j.expneurol.2026.115806_bb0915","doi-asserted-by":"crossref","first-page":"16969","DOI":"10.1523\/JNEUROSCI.4491-11.2011","article-title":"The loss of c-Jun N-terminal protein kinase activity prevents the amyloidogenic cleavage of amyloid precursor protein and the formation of amyloid plaques in vivo","volume":"31","author":"Mazzitelli","year":"2011","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb0920","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1074\/jbc.M109.081950","article-title":"Phosphorylation of synucleins by members of the Polo-like kinase family","volume":"285","author":"Mbefo","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0925","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00005072-199001000-00006","article-title":"Hippocampal neurons predisposed to neurofibrillary tangle formation are enriched in type II calcium\/calmodulin-dependent protein kinase","volume":"49","author":"McKee","year":"1990","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb0930","first-page":"1933","article-title":"Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer\u2019s disease","volume":"150","author":"McShea","year":"1997","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb0935","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1054\/mehy.1997.0680","article-title":"Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease","volume":"52","author":"McShea","year":"1999","journal-title":"Med. Hypotheses"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb0940","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbadis.2006.09.010","article-title":"Neuronal cell cycle re-entry mediates Alzheimer disease-type changes","volume":"1772","author":"McShea","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"42","key":"10.1016\/j.expneurol.2026.115806_bb0945","doi-asserted-by":"crossref","first-page":"16490","DOI":"10.1523\/JNEUROSCI.2131-13.2013","article-title":"Opposing action of nuclear factor kappaB and Polo-like kinases determines a homeostatic end point for excitatory synaptic adaptation","volume":"33","author":"Mihalas","year":"2013","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb0950","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","article-title":"The many faces of tau","volume":"70","author":"Morris","year":"2011","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb0955","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41593-018-0154-9","article-title":"A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease","volume":"21","author":"Mostafavi","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"15","key":"10.1016\/j.expneurol.2026.115806_bb0960","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1523\/JNEUROSCI.0152-05.2005","article-title":"c-Jun NH2-terminal kinase-interacting protein-3 facilitates phosphorylation and controls localization of amyloid-beta precursor protein","volume":"25","author":"Muresan","year":"2005","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115806_bb0965","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1091\/mbc.e06-07-0625","article-title":"The amyloid-beta precursor protein is phosphorylated via distinct pathways during differentiation, mitosis, stress, and degeneration","volume":"18","author":"Muresan","year":"2007","journal-title":"Mol. Biol. Cell"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb0970","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.onc.1208278","article-title":"The Plk3-Cdc25 circuit","volume":"24","author":"Myer","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0975","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s004010050665","article-title":"Cell cycle markers in the hippocampus in Alzheimer's disease","volume":"94","author":"Nagy","year":"1997","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2026.115806_bb0980","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neulet.2019.04.022","article-title":"The complexity of tau in Alzheimer's disease","volume":"705","author":"Naseri","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb0985","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40478-018-0557-6","article-title":"Phosphorylation of different tau sites during progression of Alzheimer's disease","volume":"6","author":"Neddens","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb0990","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1242\/dev.013425","article-title":"Polo kinases regulate C. elegans embryonic polarity via binding to DYRK2-primed MEX-5 and MEX-6","volume":"135","author":"Nishi","year":"2008","journal-title":"Development"},{"issue":"11","key":"10.1016\/j.expneurol.2026.115806_bb0995","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1073\/pnas.90.11.5191","article-title":"Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices","volume":"90","author":"Nitsch","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb1000","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0896-6273(03)00259-9","article-title":"Cdk5 is a key factor in tau aggregation and tangle formation in vivo","volume":"38","author":"Noble","year":"2003","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb1005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2017.06.004","article-title":"Targeting Fyn Kinase in Alzheimer's Disease","volume":"83","author":"Nygaard","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2026.115806_bb1010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer's disease","volume":"34","author":"O'Brien","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb1015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF03401803","article-title":"The cytoplasmic domain of Alzheimer\u2019s amyloid precursor protein is phosphorylated at Thr654, Ser655, and Thr668 in adult rat brain and cultured cells","volume":"3","author":"Oishi","year":"1997","journal-title":"Mol. Med."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb1020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-142664","article-title":"Amyloid-beta modulates both AbetaPP and Tau phosphorylation","volume":"45","author":"Oliveira","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb1025","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3233\/JAD-170176","article-title":"Protein phosphorylation is a key mechanism in Alzheimer's disease","volume":"58","author":"Oliveira","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"41","key":"10.1016\/j.expneurol.2026.115806_bb1030","doi-asserted-by":"crossref","first-page":"E3945","DOI":"10.1073\/pnas.1309991110","article-title":"Polo-like kinase 2 regulates selective autophagic alpha-synuclein clearance and suppresses its toxicity in vivo","volume":"110","author":"Oueslati","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5649","key":"10.1016\/j.expneurol.2026.115806_bb1035","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1126\/science.1082475","article-title":"Targeted protein degradation and synapse remodeling by an inducible protein kinase","volume":"302","author":"Pak","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb1040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0896-6273(01)00355-5","article-title":"Regulation of dendritic spine morphology by SPAR, a PSD-95-associated RapGAP","volume":"31","author":"Pak","year":"2001","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.expneurol.2026.115806_bb1045","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00018-010-0279-9","article-title":"Polo-box domain: a versatile mediator of polo-like kinase function","volume":"67","author":"Park","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00005072-199701000-00007","article-title":"Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain","volume":"56","author":"Pei","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb1055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0006-8993(98)00296-0","article-title":"Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer\u2019s disease neurofibrillary degeneration","volume":"797","author":"Pei","year":"1998","journal-title":"Brain Res."},{"issue":"1-2","key":"10.1016\/j.expneurol.2026.115806_bb1060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0169-328X(02)00488-6","article-title":"Up-regulation of mitogen-activated protein kinases ERK1\/2 and MEK1\/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease","volume":"109","author":"Pei","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115806_bb1065","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.bbadis.2016.07.005","article-title":"Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways","volume":"1862","author":"Perluigi","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"Pt 3","key":"10.1016\/j.expneurol.2026.115806_bb1070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/brain\/122.3.383","article-title":"Attention and executive deficits in Alzheimer's disease. A critical review","volume":"122","author":"Perry","year":"1999","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.expneurol.2026.115806_bb1075","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1097\/00001756-199908020-00035","article-title":"Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation","volume":"10","author":"Perry","year":"1999","journal-title":"Neuroreport"},{"issue":"5","key":"10.1016\/j.expneurol.2026.115806_bb1080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094251","article-title":"Specificity of anti-tau antibodies when analyzing mice models of Alzheimer's disease: problems and solutions","volume":"9","author":"Petry","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2026.115806_bb1085","series-title":"Placebo-controlled, Randomized, Escalating Dose Study to Evaluate the Safety and Tolerability of Four Oral Doses of NP031112, a Novel GSK3 Inhibitor, in Mild to Moderate Alzheimer's Disease Patients With Stable Anticholinesterasic Treatment","author":"Phase IIa 20 Week Double-blind","year":"2009"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb1090","first-page":"1141","article-title":"Tau protein in neurodegenerative diseases - a review","volume":"58","author":"Pirscoveanu","year":"2017","journal-title":"Romanian J. Morphol. Embryol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1095","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1186\/s12885-022-09622-0","article-title":"Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: summary of three phase I studies","volume":"22","author":"Platzbecker","year":"2022","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/ph3010042","article-title":"Role of glycogen synthase kinase-3beta in APP hyperphosphorylation induced by NMDA stimulation in cortical neurons","volume":"3","author":"Ploia","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"10.1016\/j.expneurol.2026.115806_bb1105","doi-asserted-by":"crossref","first-page":"29446","DOI":"10.3390\/ijms161226181","article-title":"New insights to clathrin and adaptor protein 2 for the design and development of therapeutic strategies","volume":"16","author":"Poulsen","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2026.115806_bb1110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fnmol.2017.00059","article-title":"An aberrant phosphorylation of amyloid precursor protein tyrosine regulates its trafficking and the binding to the clathrin endocytic complex in neural stem cells of Alzheimer's disease patients","volume":"10","author":"Poulsen","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb1115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2613.1999.00106.x","article-title":"The role of cell cycle-mediated events in Alzheimer\u2019s disease","volume":"80","author":"Raina","year":"1999","journal-title":"Int. J. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41531-023-00444-w","article-title":"Dynamic physiological alpha-synuclein S129 phosphorylation is driven by neuronal activity","volume":"9","author":"Ramalingam","year":"2023","journal-title":"NPJ. Parkinsons. Dis."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12031-007-0001-z","article-title":"Tyr687 dependent APP endocytosis and Abeta production","volume":"32","author":"Rebelo","year":"2007","journal-title":"J. Mol. Neurosci."},{"issue":"2-3","key":"10.1016\/j.expneurol.2026.115806_bb1130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000101831","article-title":"Tyrosine 687 phosphorylated Alzheimer's amyloid precursor protein is retained intracellularly and exhibits a decreased turnover rate","volume":"4","author":"Rebelo","year":"2007","journal-title":"Neurodegener. Dis."},{"issue":"51","key":"10.1016\/j.expneurol.2026.115806_bb1135","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.1523\/JNEUROSCI.2746-07.2007","article-title":"The EphA4 receptor regulates neuronal morphology through SPAR-mediated inactivation of Rap GTPases","volume":"27","author":"Richter","year":"2007","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb1140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0898-6568(00)00080-2","article-title":"The human polo-like kinase, PLK, regulates cdc2\/cyclin B through phosphorylation and activation of the cdc25C phosphatase","volume":"12","author":"Roshak","year":"2000","journal-title":"Cell. Signal."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb1145","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-2443.2002.00546.x","article-title":"SPAL, a Rap-specific GTPase activating protein, is present in the NMDA receptor-PSD-95 complex in the hippocampus","volume":"7","author":"Roy","year":"2002","journal-title":"Genes Cells"},{"issue":"9","key":"10.1016\/j.expneurol.2026.115806_bb1150","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1158\/1078-0432.CCR-08-2445","article-title":"BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity","volume":"15","author":"Rudolph","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"48","key":"10.1016\/j.expneurol.2026.115806_bb1155","doi-asserted-by":"crossref","first-page":"34850","DOI":"10.1074\/jbc.M707358200","article-title":"DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease","volume":"282","author":"Ryoo","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb1160","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1471-4159.2010.07044.x","article-title":"Phosphorylation of APP-CTF-AICD domains and interaction with adaptor proteins: signal transduction and\/or transcriptional role--relevance for Alzheimer pathology","volume":"115","author":"Schettini","year":"2010","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb1165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0197-4580(00)00110-X","article-title":"Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases","volume":"21","author":"Schwab","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"26","key":"10.1016\/j.expneurol.2026.115806_bb1170","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.1523\/JNEUROSCI.1853-08.2008","article-title":"Activity-induced Polo-like kinase 2 is required for homeostatic plasticity of hippocampal neurons during epileptiform activity","volume":"28","author":"Seeburg","year":"2008","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb1175","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.onc.1208277","article-title":"Polo-like kinases in the nervous system","volume":"24","author":"Seeburg","year":"2005","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb1180","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neuron.2008.03.021","article-title":"Critical role of CDK5 and Polo-like kinase 2 in homeostatic synaptic plasticity during elevated activity","volume":"58","author":"Seeburg","year":"2008","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb1185","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer\u2019s disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"issue":"5594","key":"10.1016\/j.expneurol.2026.115806_bb1190","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2026.115806_bb1195","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1749-6632.1996.tb34401.x","article-title":"The role of APP processing and trafficking pathways in the formation of amyloid beta-protein","volume":"777","author":"Selkoe","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1-2","key":"10.1016\/j.expneurol.2026.115806_bb1200","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1006883924775","article-title":"Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5","volume":"167","author":"Sengupta","year":"1997","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb1205","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/abbi.1998.0813","article-title":"Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules","volume":"357","author":"Sengupta","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2013.02.036","article-title":"Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer","volume":"335","author":"Seshacharyulu","year":"2013","journal-title":"Cancer Lett."},{"issue":"5594","key":"10.1016\/j.expneurol.2026.115806_bb1215","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1126\/science.1075333","article-title":"Postsynaptic signaling and plasticity mechanisms","volume":"298","author":"Sheng","year":"2002","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb1220","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00702-008-0021-z","article-title":"17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner","volume":"115","author":"Shi","year":"2008","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2026.115806_bb1225","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0169-328X(00)00245-X","article-title":"JNK activation is associated with intracellular beta-amyloid accumulation","volume":"85","author":"Shoji","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115806_bb1230","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.arcmed.2012.10.015","article-title":"Deregulated Cdk5 activity is involved in inducing Alzheimer\u2019s disease","volume":"43","author":"Shukla","year":"2012","journal-title":"Arch. Med. Res."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1235","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/biom6010006","article-title":"Tau protein hyperphosphorylation and aggregation in alzheimer's disease and other tauopathies, and possible neuroprotective strategies","volume":"6","author":"Simic","year":"2016","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.expneurol.2026.115806_bb1240","first-page":"4164","article-title":"Identification of an early-growth-response gene encoding a novel putative protein kinase","volume":"12","author":"Simmons","year":"1992","journal-title":"Mol. Cell. Biol."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2026.115806_bb1245","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0006-8993(94)90979-2","article-title":"Calcium\/calmodulin-dependent protein kinase II immunostaining is preserved in Alzheimer\u2019s disease hippocampal neurons","volume":"657","author":"Simonian","year":"1994","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1250","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1471-4159.2001.00102.x","article-title":"Phosphorylation of thr(668) in the cytoplasmic domain of the Alzheimer\u2019s disease amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3)","volume":"76","author":"Standen","year":"2001","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb1255","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cub.2006.12.037","article-title":"BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo","volume":"17","author":"Steegmaier","year":"2007","journal-title":"Curr. Biol."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115806_bb1260","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrd3184","article-title":"Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy","volume":"9","author":"Strebhardt","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb1265","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrc1841","article-title":"Targeting polo-like kinase 1 for cancer therapy","volume":"6","author":"Strebhardt","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.expneurol.2026.115806_bb1270","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101332","article-title":"PLK1 inhibition-based combination therapies for cancer management","volume":"16","author":"Su","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.expneurol.2026.115806_bb1275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.npep.2017.03.001","article-title":"The SNK and SPAR signaling pathway changes in hippocampal neurons treated with amyloid-beta peptide in vitro","volume":"63","author":"Sui","year":"2017","journal-title":"Neuropeptides"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115806_bb1280","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0306-4522(92)90264-3","article-title":"Phosphorylation of Alzheimer amyloid precursor protein by protein kinase C","volume":"48","author":"Suzuki","year":"1992","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.expneurol.2026.115806_bb1285","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/j.1460-2075.1994.tb06360.x","article-title":"Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein","volume":"13","author":"Suzuki","year":"1994","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb1290","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/hmg\/ddu475","article-title":"Comprehensive phosphoproteome analysis unravels the core signaling network that initiates the earliest synapse pathology in preclinical Alzheimer\u2019s disease brain","volume":"24","author":"Tagawa","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb1295","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.bbrc.2008.10.013","article-title":"Phosphorylation of amyloid precursor protein (APP) at Tyr687 regulates APP processing by alpha- and gamma-secretase","volume":"377","author":"Takahashi","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1300","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1038\/s41467-019-11447-8","article-title":"LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc","volume":"10","author":"Tang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2026.115806_bb1305","series-title":"The Genetics of Alzheimer Disease","volume":"2(10)","author":"Tanzi","year":"2012"},{"issue":"19","key":"10.1016\/j.expneurol.2026.115806_bb1310","doi-asserted-by":"crossref","first-page":"16798","DOI":"10.1074\/jbc.M110286200","article-title":"Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with Shc","volume":"277","author":"Tarr","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115806_bb1315","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1128\/MCB.00828-15","article-title":"Glycogen synthase kinase 3beta is positively regulated by protein kinase czeta-mediated phosphorylation induced by wnt agonists","volume":"36","author":"Tejeda-Munoz","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.expneurol.2026.115806_bb1320","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnmol.2014.00042","article-title":"Protein phosphorylation in neurodegeneration: friend or foe?","volume":"7","author":"Tenreiro","year":"2014","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115806_bb1325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004302","article-title":"Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson's disease","volume":"10","author":"Tenreiro","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.expneurol.2026.115806_bb1330","unstructured":"The Human Protein Atlas - PLK2 in brain. 2024."},{"key":"10.1016\/j.expneurol.2026.115806_bb1335","unstructured":"The Human Protein Atlas - PLK3 in brain. 2024."},{"key":"10.1016\/j.expneurol.2026.115806_bb1340","unstructured":"The Human Protein Atlas - PLK5 in brain. 2024."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2026.115806_bb1345","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11010-009-0084-7","article-title":"S655 phosphorylation enhances APP secretory traffic","volume":"328","author":"Vieira","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.expneurol.2026.115806_bb1350","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1326-5-40","article-title":"Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated","volume":"5","author":"Vieira","year":"2010","journal-title":"Mol. Neurodegener."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115806_bb1355","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/j.celrep.2018.05.048","article-title":"Sex-specific features of microglia from adult mice","volume":"23","author":"Villa","year":"2018","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115806_bb1360","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1523\/JNEUROSCI.17-10-03588.1997","article-title":"Aberrant expression of mitotic cdc2\/cyclin B1 kinase in degenerating neurons of Alzheimer\u2019s disease brain","volume":"17","author":"Vincent","year":"1997","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb1365","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.nbd.2005.05.004","article-title":"Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism","volume":"20","author":"Vingtdeux","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1370","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1182\/blood-2023-186953","article-title":"A phase 2 study with volasertib for Ven-HMA relapsed\/refractory acute myeloid leukemia patients guided by a predictive precision medicine platform","volume":"142","author":"Wagner","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb1375","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0031-6997(25)06666-9","article-title":"Protein phosphorylation and neuronal function","volume":"43","author":"Walaas","year":"1991","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb1380","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1074\/jbc.272.3.1896","article-title":"Ectodomain phosphorylation of beta-amyloid precursor protein at two distinct cellular locations","volume":"272","author":"Walter","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"31","key":"10.1016\/j.expneurol.2026.115806_bb1385","doi-asserted-by":"crossref","first-page":"23523","DOI":"10.1074\/jbc.M002850200","article-title":"Phosphorylation of the beta-amyloid precursor protein at the cell surface by ectocasein kinases 1 and 2","volume":"275","author":"Walter","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115806_bb1390","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107908","article-title":"Meta-analysis of the Alzheimer's disease human brain transcriptome and functional dissection in mouse models","volume":"32","author":"Wan","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1395","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.brainres.2004.10.061","article-title":"The expression of calcium\/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer\u2019s disease and its links with AD-related pathology","volume":"1031","author":"Wang","year":"2005","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1400","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1460-9568.2006.05226.x","article-title":"Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration","volume":"25","author":"Wang","year":"2007","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1405","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4161\/15384101.2014.986392","article-title":"Regulation of polo-like kinase 1 by DNA damage and PP2A\/B55alpha","volume":"14","author":"Wang","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.expneurol.2026.115806_bb1410","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fnmol.2017.00294","article-title":"Modifications and trafficking of APP in the pathogenesis of Alzheimer's disease","volume":"10","author":"Wang","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115806_bb1415","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.185","article-title":"The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease","volume":"5","author":"Wang","year":"2018","journal-title":"Sci Data"},{"key":"10.1016\/j.expneurol.2026.115806_bb1420","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.conb.2021.03.003","article-title":"A current view on Tau protein phosphorylation in Alzheimer's disease","volume":"69","author":"Wegmann","year":"2021","journal-title":"Curr. Opin. Neurobiol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1425","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113181","article-title":"PLK2 targets GSK3beta to protect against cisplatin-induced acute kidney injury","volume":"417","author":"Wei","year":"2022","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.expneurol.2026.115806_bb1430","article-title":"Effectiveness, safety and pharmacokinetics of Polo-like kinase 1 inhibitors in tumor therapy: A systematic review and meta-analysis","volume":"13","author":"Wei","year":"2023","journal-title":"Front. Oncol."},{"issue":"19","key":"10.1016\/j.expneurol.2026.115806_bb1435","doi-asserted-by":"crossref","first-page":"13805","DOI":"10.1074\/jbc.M601101200","article-title":"ProSAP-interacting protein 1 (ProSAPiP1), a novel protein of the postsynaptic density that links the spine-associated Rap-Gap (SPAR) to the scaffolding protein ProSAP2\/Shank3","volume":"281","author":"Wendholt","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb1440","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","article-title":"Tau PTM profiles identify patient heterogeneity and stages of Alzheimer's disease","volume":"183","author":"Wesseling","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2026.115806_bb1445","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100273","article-title":"Genetic deletion of Polo-like kinase 2 reduces alpha-synuclein serine-129 phosphorylation in presynaptic terminals but not Lewy bodies","volume":"296","author":"Weston","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2026.115806_bb1450","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brainres.2007.06.082","article-title":"Involvement of the Snk-SPAR pathway in glutamate-induced excitotoxicity in cultured hippocampal neurons","volume":"1168","author":"Wu","year":"2007","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1455","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-021-00460-5","article-title":"\"Don't Phos Over Tau\": recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies","volume":"16","author":"Xia","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115806_bb1460","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/00005072-199609000-00002","article-title":"alpha-calcium-calmodulin-dependent kinase II is associated with paired helical filaments of Alzheimer\u2019s disease","volume":"55","author":"Xiao","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2026.115806_bb1465","article-title":"Alpha-synuclein in Parkinson's disease: from pathogenetic dysfunction to potential clinical application","volume":"2016","author":"Xu","year":"2016","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2026.115806_bb1470","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1479-5876-12-165","article-title":"Ecto-protein kinases and phosphatases: an emerging field for translational medicine","volume":"12","author":"Yalak","year":"2014","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb1475","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s004010050513","article-title":"Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I\/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II","volume":"92","author":"Yamaguchi","year":"1996","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2026.115806_bb1480","first-page":"321","article-title":"c-Jun N-terminal Kinase (JNK) Signaling as a therapeutic target for Alzheimer's disease","volume":"6","author":"Yarza","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1485","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0006-8993(00)02200-9","article-title":"Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain","volume":"865","author":"Yasojima","year":"2000","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115806_bb1490","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.neurobiolaging.2015.03.013","article-title":"The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity","volume":"36","author":"Yin","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2026.115806_bb1495","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172415","article-title":"Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer's disease development: an up-to-date review","volume":"856","author":"Yuksel","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb1500","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1471-4159.2012.07737.x","article-title":"Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer\u2019s disease patients","volume":"121","author":"Zahid","year":"2012","journal-title":"J. Neurochem."},{"issue":"23","key":"10.1016\/j.expneurol.2026.115806_bb1505","doi-asserted-by":"crossref","first-page":"19787","DOI":"10.1074\/jbc.M100792200","article-title":"The beta-amyloid precursor protein APP is tyrosine-phosphorylated in cells expressing a constitutively active form of the Abl protoncogene","volume":"276","author":"Zambrano","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115806_bb1510","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3736\/jcim20090309","article-title":"Protective effect of spleen-yin-nourishing recipe on amyloid beta-peptide-induced damage of primarily cultured rat hippocampal neurons and its mechanism","volume":"7","author":"Zhan","year":"2009","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115806_bb1515","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010209","article-title":"Phosphorylation signaling in APP processing in Alzheimer's disease","volume":"21","author":"Zhang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115806_bb1520","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between Abeta and Tau in the Pathogenesis of Alzheimer's disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.expneurol.2026.115806_bb1525","article-title":"Polo-Like kinase 2: from principle to practice","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"issue":"24","key":"10.1016\/j.expneurol.2026.115806_bb1530","doi-asserted-by":"crossref","first-page":"25374","DOI":"10.1074\/jbc.M400488200","article-title":"Growth factor receptor-bound protein 2 interaction with the tyrosine-phosphorylated tail of amyloid beta precursor protein is mediated by its Src homology 2 domain","volume":"279","author":"Zhou","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115806_bb1535","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/jnen\/59.10.880","article-title":"Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease","volume":"59","author":"Zhu","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115806_bb1540","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0197-4580(00)00217-7","article-title":"Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease","volume":"21","author":"Zhu","year":"2000","journal-title":"Neurobiol. Aging"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626001706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626001706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:49:35Z","timestamp":1794563375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488626001706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":308,"alternative-id":["S0014488626001706"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115806","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging role of polo-like kinase 2 in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115806"}}